Archives
SARS-CoV-2 NSP15 Inhibitors: Screening Insights
2026-08-19
The 2021 reference study used structure-based virtual screening and molecular dynamics simulations to identify thymopentin and oleuropein as high-priority candidate inhibitors of SARS-CoV-2 NSP15. Its main contribution is a computational route toward targeting viral immune evasion, although biochemical, cellular, pharmacokinetic, and clinical validation remain necessary.
E3 Deletion and CAdV-2 Pathogenicity in Dogs
2026-08-18
The reference study identified a novel canine adenovirus type 2 strain carrying a 9-nucleotide E3 deletion that truncated the encoded protein by three amino acids. Experimental canine infections showed that this variant retained virulence comparable to wild-type isolates, emphasizing that E3 sequence variation should not automatically be interpreted as attenuation.
Entecavir: From Polymerase Mechanism to Translation
2026-08-18
Entecavir, also known as BMS200475, illustrates how a precisely defined antiviral mechanism can guide resistance modeling, cccDNA interpretation, assay design, and translational strategy. This thought-leadership review connects molecular pharmacology with experimental execution and clinical relevance in chronic hepatitis B research.
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-08-17
Oh et al. establish a scalable human induced pluripotent stem cell-derived sensory neuron system that supports HSV-1 latency and stimulus-induced reactivation. The model combines neuronal functional validation with virological, transcriptional, and chromatin-based criteria, providing a stronger human-relevant platform for studying latency mechanisms and evaluating future interventions.
From CRISPR Hits to RNA-Ready Translation
2026-08-17
A mechanistic and strategic guide to using T7 RNA polymerase transcription to validate PCMT1-driven ovarian cancer biology, design functional RNA experiments, and evaluate high-yield synthesis platforms for translational research.
Neticonazole Hydrochloride: From Mycosis to Models
2026-08-16
Neticonazole Hydrochloride is an imidazole antifungal with established topical relevance and emerging value in colorectal cancer research. This article focuses on evidence boundaries, assay design, and how targeted oral delivery concepts can inform—not replace—mechanistic studies of exosome inhibition and apoptosis.
Cardiogreen for NIR PDT and Vascular Imaging
2026-08-15
Cardiogreen (Indocyanine Green) connects near-infrared vascular visualization with controllable photodynamic and photothermal workflows. This guide translates its validated optical, formulation, and storage characteristics into reproducible cell-assay, imaging, and translational oncology practices.
GOB-38 Biochemistry in Elizabethkingia anophelis
2026-08-14
Liu and colleagues characterized GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, and found activity against penicillins, cephalosporins, and carbapenems. The study links active-site variation with substrate preference and uses co-culture evidence to raise the possibility that E. anophelis may contribute to carbapenem-resistance dissemination during polymicrobial infection.
Maternal IL-17A and Neonatal GBS Risk
2026-08-14
A prospective mother–newborn study in Morocco links reduced maternal IL-17A responses with invasive Group B Streptococcus disease in newborns. Its combination of cytokine profiling, paired maternal–cord blood analysis, and ex vivo pathogen-recognition receptor stimulation supports IL-17A as a candidate biomarker for neonatal risk stratification.
2',7'-Dichlorofluorescein Diacetate for ROS Assays
2026-08-13
Build reproducible intracellular ROS measurement workflows with a cell-permeable fluorescent probe that supports microscopy, flow cytometry, and plate-based readouts. Learn how to translate redox findings from a ROS-responsive pancreatic cancer nanocarrier study into practical assay controls, optimization steps, and interpretation limits.
Phebestin Reveals a New Antiplasmodial Strategy
2026-08-13
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial compound active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its combination of broad blood-stage activity, post-exposure effects, computational target engagement, and efficacy in rodent malaria models provides a useful framework for evaluating parasite aminopeptidases as drug targets.
ROS Readouts for Smarter Nanomedicine Translation
2026-08-12
A mechanistic and strategic guide to using 2′,7′-Dichlorofluorescein diacetate for interpreting oxidative stress in ROS-responsive nanomedicine, with practical assay guidance and translational limitations drawn from recent pancreatic cancer research.
Tc3-Induced Pyroptosis in Hepatic Carcinoma
2026-08-12
The reference study identifies the indole analogue Tc3 as a hepatic carcinoma inhibitor that promotes PRDX1-associated oxidative stress, endoplasmic reticulum stress, and GSDME-mediated pyroptosis. Its combination with cisplatin or anti-PD-1 therapy produced stronger antitumor effects in experimental models, while GSDME expression and CD8+ T-cell infiltration emerged as important translational considerations.
Alfuzosin HCl: Assay Workflows for BPH Research
2026-08-11
Build practical Alfuzosin HCl workflows for receptor pharmacology, formulation testing, and low-cost spectrophotometric quality control. The guide translates a validated binary-mixture assay into calibration, release-testing, troubleshooting, and translational research decisions.
2',7'-Dichlorofluorescein Diacetate in ROS Assays
2026-08-11
2',7'-Dichlorofluorescein diacetate is a versatile fluorescent ROS probe, but its signal is best interpreted as an integrated oxidative-stress readout rather than a molecule-specific measurement. This article connects assay design with the ROS-responsive nanocarrier strategy reported for pancreatic cancer, providing a practical framework for microscopy, flow cytometry, and plate-based studies.
603 records 11/41 page Previous Next First page 上5页 1112131415 下5页 Last page